Copper Coordination Compounds as Biologically Active Agents

Copper-containing coordination compounds attract wide attention due to the redox activity and biogenicity of copper ions, providing multiple pathways of biological activity. The pharmacological properties of metal complexes can be fine-tuned by varying the nature of the ligand and donor atoms. Coppe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular sciences 2020-05, Vol.21 (11), p.3965
Hauptverfasser: Krasnovskaya, Olga, Naumov, Alexey, Guk, Dmitry, Gorelkin, Peter, Erofeev, Alexander, Beloglazkina, Elena, Majouga, Alexander
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 11
container_start_page 3965
container_title International journal of molecular sciences
container_volume 21
creator Krasnovskaya, Olga
Naumov, Alexey
Guk, Dmitry
Gorelkin, Peter
Erofeev, Alexander
Beloglazkina, Elena
Majouga, Alexander
description Copper-containing coordination compounds attract wide attention due to the redox activity and biogenicity of copper ions, providing multiple pathways of biological activity. The pharmacological properties of metal complexes can be fine-tuned by varying the nature of the ligand and donor atoms. Copper-containing coordination compounds are effective antitumor agents, constituting a less expensive and safer alternative to classical platinum-containing chemotherapy, and are also effective as antimicrobial, antituberculosis, antimalarial, antifugal, and anti-inflammatory drugs. Сu-labeled coordination compounds are promising PET imaging agents for diagnosing malignant pathologies, including head and neck cancer, as well as the hallmark of Alzheimer's disease amyloid-β (Aβ). In this review article, we summarize different strategies for possible use of coordination compounds in the treatment and diagnosis of various diseases, and also various studies of the mechanisms of antitumor and antimicrobial action.
doi_str_mv 10.3390/ijms21113965
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7312030</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32486510</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-8bbb769b213618afe7996494119658d30e0a0d50cd5c9dd6225fb1692a95a0553</originalsourceid><addsrcrecordid>eNpVkF9LwzAUxYMobk7ffJZ-AKs3SZM2CMJW_AcDX_Q5pEk6M9qmJN1g397KdMyney_33N-5HISuMdxRKuDerdtIMMZUcHaCpjgjJAXg-elRP0EXMa4BCCVMnKMJJVnBGYYpeih939uQlN4H4zo1ON-NQ9v7TWdiomKycL7xK6dV0-ySuR7c1ibzle2GeInOatVEe_VbZ-jz-emjfE2X7y9v5XyZ6ozBkBZVVeVcVARTjgtV21wInokM4_HjwlCwoMAw0IZpYQwnhNUV5oIowRQwRmfocc_tN1VrjR69g2pkH1yrwk565eT_Tee-5MpvZU4xAQoj4HYP0MHHGGx9uMUgf0KUxyGO8ptjv4P4LzX6DReFbek</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Copper Coordination Compounds as Biologically Active Agents</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><creator>Krasnovskaya, Olga ; Naumov, Alexey ; Guk, Dmitry ; Gorelkin, Peter ; Erofeev, Alexander ; Beloglazkina, Elena ; Majouga, Alexander</creator><creatorcontrib>Krasnovskaya, Olga ; Naumov, Alexey ; Guk, Dmitry ; Gorelkin, Peter ; Erofeev, Alexander ; Beloglazkina, Elena ; Majouga, Alexander</creatorcontrib><description>Copper-containing coordination compounds attract wide attention due to the redox activity and biogenicity of copper ions, providing multiple pathways of biological activity. The pharmacological properties of metal complexes can be fine-tuned by varying the nature of the ligand and donor atoms. Copper-containing coordination compounds are effective antitumor agents, constituting a less expensive and safer alternative to classical platinum-containing chemotherapy, and are also effective as antimicrobial, antituberculosis, antimalarial, antifugal, and anti-inflammatory drugs. Сu-labeled coordination compounds are promising PET imaging agents for diagnosing malignant pathologies, including head and neck cancer, as well as the hallmark of Alzheimer's disease amyloid-β (Aβ). In this review article, we summarize different strategies for possible use of coordination compounds in the treatment and diagnosis of various diseases, and also various studies of the mechanisms of antitumor and antimicrobial action.</description><identifier>ISSN: 1422-0067</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms21113965</identifier><identifier>PMID: 32486510</identifier><language>eng</language><publisher>Switzerland: MDPI</publisher><subject>Alzheimer Disease - drug therapy ; Amyloid beta-Peptides - chemistry ; Animals ; Anti-Infective Agents - therapeutic use ; Antineoplastic Agents - therapeutic use ; Biological Factors - chemistry ; Cell Line, Tumor ; Copper - chemistry ; Drug Design ; Drug Evaluation, Preclinical ; Flow Cytometry ; HEK293 Cells ; Humans ; Inhibitory Concentration 50 ; Ions ; Isotopes - chemistry ; Ligands ; MCF-7 Cells ; Mycobacterium tuberculosis ; Oxidation-Reduction ; Positron-Emission Tomography ; Review ; Spectrophotometry ; Tetrazolium Salts - pharmacology ; Thiazoles - pharmacology ; Tuberculosis - drug therapy</subject><ispartof>International journal of molecular sciences, 2020-05, Vol.21 (11), p.3965</ispartof><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-8bbb769b213618afe7996494119658d30e0a0d50cd5c9dd6225fb1692a95a0553</citedby><cites>FETCH-LOGICAL-c450t-8bbb769b213618afe7996494119658d30e0a0d50cd5c9dd6225fb1692a95a0553</cites><orcidid>0000-0002-4860-9013 ; 0000-0002-5674-8654</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312030/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312030/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32486510$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Krasnovskaya, Olga</creatorcontrib><creatorcontrib>Naumov, Alexey</creatorcontrib><creatorcontrib>Guk, Dmitry</creatorcontrib><creatorcontrib>Gorelkin, Peter</creatorcontrib><creatorcontrib>Erofeev, Alexander</creatorcontrib><creatorcontrib>Beloglazkina, Elena</creatorcontrib><creatorcontrib>Majouga, Alexander</creatorcontrib><title>Copper Coordination Compounds as Biologically Active Agents</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Copper-containing coordination compounds attract wide attention due to the redox activity and biogenicity of copper ions, providing multiple pathways of biological activity. The pharmacological properties of metal complexes can be fine-tuned by varying the nature of the ligand and donor atoms. Copper-containing coordination compounds are effective antitumor agents, constituting a less expensive and safer alternative to classical platinum-containing chemotherapy, and are also effective as antimicrobial, antituberculosis, antimalarial, antifugal, and anti-inflammatory drugs. Сu-labeled coordination compounds are promising PET imaging agents for diagnosing malignant pathologies, including head and neck cancer, as well as the hallmark of Alzheimer's disease amyloid-β (Aβ). In this review article, we summarize different strategies for possible use of coordination compounds in the treatment and diagnosis of various diseases, and also various studies of the mechanisms of antitumor and antimicrobial action.</description><subject>Alzheimer Disease - drug therapy</subject><subject>Amyloid beta-Peptides - chemistry</subject><subject>Animals</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Biological Factors - chemistry</subject><subject>Cell Line, Tumor</subject><subject>Copper - chemistry</subject><subject>Drug Design</subject><subject>Drug Evaluation, Preclinical</subject><subject>Flow Cytometry</subject><subject>HEK293 Cells</subject><subject>Humans</subject><subject>Inhibitory Concentration 50</subject><subject>Ions</subject><subject>Isotopes - chemistry</subject><subject>Ligands</subject><subject>MCF-7 Cells</subject><subject>Mycobacterium tuberculosis</subject><subject>Oxidation-Reduction</subject><subject>Positron-Emission Tomography</subject><subject>Review</subject><subject>Spectrophotometry</subject><subject>Tetrazolium Salts - pharmacology</subject><subject>Thiazoles - pharmacology</subject><subject>Tuberculosis - drug therapy</subject><issn>1422-0067</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkF9LwzAUxYMobk7ffJZ-AKs3SZM2CMJW_AcDX_Q5pEk6M9qmJN1g397KdMyney_33N-5HISuMdxRKuDerdtIMMZUcHaCpjgjJAXg-elRP0EXMa4BCCVMnKMJJVnBGYYpeih939uQlN4H4zo1ON-NQ9v7TWdiomKycL7xK6dV0-ySuR7c1ibzle2GeInOatVEe_VbZ-jz-emjfE2X7y9v5XyZ6ozBkBZVVeVcVARTjgtV21wInokM4_HjwlCwoMAw0IZpYQwnhNUV5oIowRQwRmfocc_tN1VrjR69g2pkH1yrwk565eT_Tee-5MpvZU4xAQoj4HYP0MHHGGx9uMUgf0KUxyGO8ptjv4P4LzX6DReFbek</recordid><startdate>20200531</startdate><enddate>20200531</enddate><creator>Krasnovskaya, Olga</creator><creator>Naumov, Alexey</creator><creator>Guk, Dmitry</creator><creator>Gorelkin, Peter</creator><creator>Erofeev, Alexander</creator><creator>Beloglazkina, Elena</creator><creator>Majouga, Alexander</creator><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4860-9013</orcidid><orcidid>https://orcid.org/0000-0002-5674-8654</orcidid></search><sort><creationdate>20200531</creationdate><title>Copper Coordination Compounds as Biologically Active Agents</title><author>Krasnovskaya, Olga ; Naumov, Alexey ; Guk, Dmitry ; Gorelkin, Peter ; Erofeev, Alexander ; Beloglazkina, Elena ; Majouga, Alexander</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-8bbb769b213618afe7996494119658d30e0a0d50cd5c9dd6225fb1692a95a0553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Alzheimer Disease - drug therapy</topic><topic>Amyloid beta-Peptides - chemistry</topic><topic>Animals</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Biological Factors - chemistry</topic><topic>Cell Line, Tumor</topic><topic>Copper - chemistry</topic><topic>Drug Design</topic><topic>Drug Evaluation, Preclinical</topic><topic>Flow Cytometry</topic><topic>HEK293 Cells</topic><topic>Humans</topic><topic>Inhibitory Concentration 50</topic><topic>Ions</topic><topic>Isotopes - chemistry</topic><topic>Ligands</topic><topic>MCF-7 Cells</topic><topic>Mycobacterium tuberculosis</topic><topic>Oxidation-Reduction</topic><topic>Positron-Emission Tomography</topic><topic>Review</topic><topic>Spectrophotometry</topic><topic>Tetrazolium Salts - pharmacology</topic><topic>Thiazoles - pharmacology</topic><topic>Tuberculosis - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Krasnovskaya, Olga</creatorcontrib><creatorcontrib>Naumov, Alexey</creatorcontrib><creatorcontrib>Guk, Dmitry</creatorcontrib><creatorcontrib>Gorelkin, Peter</creatorcontrib><creatorcontrib>Erofeev, Alexander</creatorcontrib><creatorcontrib>Beloglazkina, Elena</creatorcontrib><creatorcontrib>Majouga, Alexander</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krasnovskaya, Olga</au><au>Naumov, Alexey</au><au>Guk, Dmitry</au><au>Gorelkin, Peter</au><au>Erofeev, Alexander</au><au>Beloglazkina, Elena</au><au>Majouga, Alexander</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Copper Coordination Compounds as Biologically Active Agents</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2020-05-31</date><risdate>2020</risdate><volume>21</volume><issue>11</issue><spage>3965</spage><pages>3965-</pages><issn>1422-0067</issn><eissn>1422-0067</eissn><abstract>Copper-containing coordination compounds attract wide attention due to the redox activity and biogenicity of copper ions, providing multiple pathways of biological activity. The pharmacological properties of metal complexes can be fine-tuned by varying the nature of the ligand and donor atoms. Copper-containing coordination compounds are effective antitumor agents, constituting a less expensive and safer alternative to classical platinum-containing chemotherapy, and are also effective as antimicrobial, antituberculosis, antimalarial, antifugal, and anti-inflammatory drugs. Сu-labeled coordination compounds are promising PET imaging agents for diagnosing malignant pathologies, including head and neck cancer, as well as the hallmark of Alzheimer's disease amyloid-β (Aβ). In this review article, we summarize different strategies for possible use of coordination compounds in the treatment and diagnosis of various diseases, and also various studies of the mechanisms of antitumor and antimicrobial action.</abstract><cop>Switzerland</cop><pub>MDPI</pub><pmid>32486510</pmid><doi>10.3390/ijms21113965</doi><orcidid>https://orcid.org/0000-0002-4860-9013</orcidid><orcidid>https://orcid.org/0000-0002-5674-8654</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2020-05, Vol.21 (11), p.3965
issn 1422-0067
1422-0067
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7312030
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central
subjects Alzheimer Disease - drug therapy
Amyloid beta-Peptides - chemistry
Animals
Anti-Infective Agents - therapeutic use
Antineoplastic Agents - therapeutic use
Biological Factors - chemistry
Cell Line, Tumor
Copper - chemistry
Drug Design
Drug Evaluation, Preclinical
Flow Cytometry
HEK293 Cells
Humans
Inhibitory Concentration 50
Ions
Isotopes - chemistry
Ligands
MCF-7 Cells
Mycobacterium tuberculosis
Oxidation-Reduction
Positron-Emission Tomography
Review
Spectrophotometry
Tetrazolium Salts - pharmacology
Thiazoles - pharmacology
Tuberculosis - drug therapy
title Copper Coordination Compounds as Biologically Active Agents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T16%3A56%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Copper%20Coordination%20Compounds%20as%20Biologically%20Active%20Agents&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Krasnovskaya,%20Olga&rft.date=2020-05-31&rft.volume=21&rft.issue=11&rft.spage=3965&rft.pages=3965-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms21113965&rft_dat=%3Cpubmed_cross%3E32486510%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32486510&rfr_iscdi=true